Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of molecularly targeted drugs. The company helps in discovering new compounds that are targeted at tumor signaling pathways in patients with specific genetic mutations.
You’re viewing a free company profile from the PitchBook Platform. To explore NantBioscience’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.